REG - AIM - AIM Notice - 16/12/2025

Alien MetalsAnnouncement

Yesterday 09:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251216:nRSP6367La&default-theme=true

RNS Number : 6367L  AIM  16 December 2025

NOTICE

 

16/12/2025 - 08:00

 

The London Stock Exchange admits the following securities to trading on AIM:

 

 ALIEN METALS LIMITED
 2,000,000,000  COMMON SHARES OF NO PAR VALUE, FULLY PAID, (DI)  (BGRSF03)(VGG017351021)

 

 ALIEN METALS LIMITED
 277,777,777  COMMON SHARES OF NO PAR VALUE, FULLY PAID, (DI)  (BGRSF03)(VGG017351021)

 

 ATLANTIC LITHIUM LIMITED
 217,720  ORDINARY SHARES OF NO PAR VALUE FULLY PAID (DI)  (BPWBM76)(AU0000237554)

 

 CelLBxHealth plc
 9,090,000  ORDINARY SHARES OF 0.05P EACH, FULLY PAID  (3433067)(GB0034330679)

 

 CRISM Therapeutics Corporation
 662,332  ORDINARY SHARES OF NO PAR VALUE, FULLY PAID  (BS60QF6)(VGG042401262)

 

 Mercantile Ports & Logistics Limited
 136,819,712  ORDINARY SHARES OF NO PAR VALUE, FULLY PAID  (BKSH7R8)(GG00BKSH7R87)

 

 Orosur Mining Inc
 666,664  COMMON SHARES OF NO PAR VALUE, FULLY PAID  (B03N6X0)(CA6871961059)

 

 Panthera Resources plc
 2,398,330  ORDINARY SHARES OF 1P EACH, FULLY PAID  (BD2B4L0)(GB00BD2B4L05)

 

 Pathos Communications plc
 66,666,666  ORDINARY SHARES OF GBP0.001 EACH, FULLY PAID  (BTWSXW7)(GB00BTWSXW71)

 

AMENDMENT

 

Following a Capital Reorganisation the following security has been amended:

 

 CelLBxHealth plc
   ORDINARY SHARES OF 10P EACH, FULLY PAID  (3433067)(GB0034330679)

 

These should appear as:

 

 CelLBxHealth plc
   ORDINARY SHARES OF 0.05P EACH, FULLY PAID  (3433067)(GB0034330679)

 

If you have any queries or require further information, please contact Market
Operations on 020 7797 4310.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  AMOBUBDDDSBDGUU



            Copyright 2019 Regulatory News Service, all rights reserved